drugset
drugset / Trial / NCT00652600

Bioavailability Study of Propranolol Under Fed Conditions

NCT00652600 ↗

Phase 1 Completed 46 enrolled Par Pharmaceutical, Inc. SFBC Anapharm · collab
RandomizedCrossoverOpen-labelOther

Summary

To compare the single-dose bioavailability of Propranolol 160 Mg ER Capsules with Inderal-La

Timeline

Start
2005-09
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 160 mg —

Indications

No indication recorded.